In keeping with its mission to regulate tobacco products and protect the public health, the FDA Center for Tobacco Products (CTP) is committed to understanding how people use the myriad of diverse tobacco products available and the resulting exposure to toxins and addictive chemicals. As a strong first step to guide research efforts, the FDA CTP has established, based on peer-reviewed toxicological findings, a list of harmful and potentially harmful constituents to health (HPHCs) that may be inhaled, ingested, or absorbed as a result of tobacco product use. The HPHCs include carcinogens, respiratory, cardiovascular, reproductive, and developmental toxicants: all of these chemicals are known components of tobacco products. Starting in 2013, FDA-mandated reporting of the quantities of HPHCs in tobacco products will be required of the tobacco industry. Although tobacco product emissions and content are important components of a product's overall toxicity, user behavior and resulting human exposures are critical to understanding the difference in harm among the many tobacco product types and brands available. This project is designed to inform the FDA CTP's ongoing efforts to quantify actual human exposures, and identify and measure toxins that directly contribute to the risk of tobacco use-related disease. The scientific potency of traditional biomarker monitoring data hinges on the assumption that all of the study subjects faithfully and solely use the test product for prolonged periods. We know that most tobacco users, having the highest brand loyalty of all consumers, often do not comply with this requirement. The human behavior and exposure data that will be collected in support of this project are designed to enhance traditional biomarkers by providing a body of data that is not confounded by subject non-compliance, as these data are collected before and immediately after direct use of the tobacco products. Using a combination of human crossover trials and an established boost method paradigm, the relative exposures to HPHCs from new and manipulated tobacco products will be measured. These defensible objective data will be supported by a robust Quality Assurance/Quality Control program, and will be made available rapidly to FDA CTP and other collaborating Centers to inform tobacco regulation via a secure, privilege-based internet accessible database.

Public Health Relevance

Using human crossover trials and an established boost measurement paradigm, this study will measure relative exposures to HPHCs from new and manipulated tobacco products. Novel behavior and exposure measurement methods have been established for use with smoked and electronic cigarettes, flavored cigars, waterpipes, and smokeless tobacco products.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BDCN-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland College Park
College Park
United States
Zip Code
Ghosh, Arijit; Woolum, Karen; Knopp, Michael V et al. (2018) Development and optimization of a novel automated loop method for production of [11C]nicotine. Appl Radiat Isot 140:76-82
Halpern-Felsher, Bonnie; Kim, Hyoshin (2018) Measuring E-cigarette use, dependence, and perceptions: Important principles and considerations to advance tobacco regulatory science. Addict Behav 79:201-202
Mead, Erin L; Cruz-Cano, Raul; Groom, Allison et al. (2018) Responses to cigarette health warning labels, harm perceptions and knowledge in a national sample of pregnant and non-pregnant women of reproductive age. Addict Behav 90:10-13
Mead, Erin L; Johnson, Sarah Lindstrom; Siddiqui, Junaed et al. (2018) Beyond blunts: Reasons for cigarette and cigar use among African American young adult dual users. Addict Res Theory 26:349-360
Mikheev, Vladimir B; Buehler, Stephanie S; Brinkman, Marielle C et al. (2018) The application of commercially available mobile cigarette topography devices for e-cigarette vaping behavior measurements. Nicotine Tob Res :
Weaver, Scott R; Kim, Hyoshin; Glasser, Allison M et al. (2018) Establishing consensus on survey measures for electronic nicotine and non-nicotine delivery system use: Current challenges and considerations for researchers. Addict Behav 79:203-212
Hamad, Samera H; Johnson, Nathan M; Tefft, Margaret E et al. (2017) Little Cigars vs 3R4F Cigarette: Physical Properties and HPHC Yields. Tob Regul Sci 3:459-478
Chopyk, Jessica; Chattopadhyay, Suhana; Kulkarni, Prachi et al. (2017) Mentholation affects the cigarette microbiota by selecting for bacteria resistant to harsh environmental conditions and selecting against potential bacterial pathogens. Microbiome 5:22
Kim, Hyoshin; Davis, Andrew H; Dohack, Jaime L et al. (2017) E-Cigarettes Use Behavior and Experience of Adults: Qualitative Research Findings to Inform E-Cigarette Use Measure Development. Nicotine Tob Res 19:190-196
Chen, Julia Cen; Das, Babita; Mead, Erin L et al. (2017) Flavored E-cigarette Use and Cigarette Smoking Susceptibility among Youth. Tob Regul Sci 3:68-80

Showing the most recent 10 out of 20 publications